Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Daclizumab (Anti-IL-2Ra / CD25) For research use only.
Not for use in humans.

Daclizumab (Anti-IL-2Ra / CD25)

Synonyms: Zenapax, Ro 24-7375

Daclizumab (Anti-IL-2Ra / CD25) is a recombinant monoclonal antibody interleukin-2 receptor antagonist. MW:145.5 KD.

Daclizumab (Anti-IL-2Ra / CD25)

Purity & Quality Control

Batch: A243401 Purity: 99% Protein concentration: 19.92mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Daclizumab (Anti-IL-2Ra / CD25) is a recombinant monoclonal antibody interleukin-2 receptor antagonist. MW:145.5 KD.

Product Details

CAS No. 152923-56-3
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Daclizumab (Anti-IL-2Ra / CD25) | Daclizumab (Anti-IL-2Ra / CD25) supplier | purchase Daclizumab (Anti-IL-2Ra / CD25) | Daclizumab (Anti-IL-2Ra / CD25) cost | Daclizumab (Anti-IL-2Ra / CD25) manufacturer | order Daclizumab (Anti-IL-2Ra / CD25) | Daclizumab (Anti-IL-2Ra / CD25) distributor